Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
Pharma
Teva's 1st R&D day lets CEO bask in innovative drug refresh
TD Cowen analysts left Teva's first R&D day this week feeling “increasingly confident” in the firm’s direction.
Fraiser Kansteiner
,
Donavyn Coffey
Nov 13, 2026 11:16am
GSK runs first DTC ad for would-be asthma blockbuster Exdensur
Jun 17, 2026 11:55am
AZ's Breztri picks up 2nd FDA nod, unlocking asthma market
Apr 28, 2026 10:47am
GSK used Flovent generic partner to 'game the system': senator
Mar 17, 2026 5:05pm
Glenmark gains FDA nod for first 'true' generic of GSK's Flovent
Mar 5, 2026 12:40pm
Insmed forecasts sales of Brinsupri will reach $1B in 2026
Feb 19, 2026 11:45am
